Resources

Learn more about the strategic alliance between Simtra BioPharma Solutions and MilliporeSigma in this joint presentation focused on streamlining Antibody Drug Conjugate (ADC) development and manufacturing—from drug substance to drug product.

Learn more about the Simtra BioPharma Solutions–MilliporeSigma alliance which represents quality-first ADC manufacturing and enables pharma and biopharma companies to focus on continued drug discovery that advances treatment options for patients worldwide.

Learn more about Simtra BioPharma Solutions’ antibody drug conjugate (ADC) services during an expert-led presentation.

Learn more about Simtra BioPharma Solutions’ development and pre-commercial services during an expert-led presentation.

At Simtra, sustainability is about more than environmental responsibility. It reflects our commitment to community engagement, quality standards, strong governance, and future-ready growth.

As Antibody Drug Conjugates (ADCs) become the future standard of cancer therapy, Simtra BioPharma Solutions is a trusted partner for Pharmaceutical and Biotech companies developing complex therapies.

Both our Bloomington and Halle/Westfalen facilities have earned numerous industry awards for manufacturing excellence in various categories over the last two decades.

As a premier independent contract development and manufacturing (CDMO), Simtra helps pharmaceutical and biotechnology companies develop and produce high quality sterile injectables for their patients globally.

With a focus on the future, Simtra is expanding capacity and capabilities at both of its facilities.